Gareth Morgan Investments Limited Partnership reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 63,705 shares of the healthcare conglomerate’s stock after selling 15,323 shares during the period. UnitedHealth Group accounts for about 1.1% of Gareth Morgan Investments Limited Partnership’s holdings, making the stock its 15th biggest holding. Gareth Morgan Investments Limited Partnership’s holdings in UnitedHealth Group were worth $11,812,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC increased its position in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after purchasing an additional 603 shares during the last quarter. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the second quarter worth about $110,000. Kings Point Capital Management increased its position in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after purchasing an additional 150 shares during the last quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its position in UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the last quarter. Finally, BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the second quarter worth about $121,000. Hedge funds and other institutional investors own 86.17% of the company’s stock.
Several equities research analysts recently issued reports on UNH shares. Royal Bank Of Canada restated a “buy” rating and set a $212.00 price objective on shares of UnitedHealth Group in a research report on Thursday, July 20th. BidaskClub cut shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. Mizuho set a $235.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, July 18th. Citigroup Inc. raised their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research report on Wednesday, July 19th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective for the company in a research report on Tuesday, August 1st. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $216.65.
UnitedHealth Group Incorporated (UNH) opened at $211.07 on Friday. UnitedHealth Group Incorporated has a 12 month low of $146.01 and a 12 month high of $213.93. The company has a quick ratio of 0.72, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. The stock has a market cap of $205,015.92, a P/E ratio of 22.04, a P/E/G ratio of 1.57 and a beta of 0.64.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. During the same quarter in the previous year, the firm earned $2.17 earnings per share. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. equities research analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 33.26%.
In related news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders sold 72,149 shares of company stock valued at $14,212,342 in the last quarter. 0.89% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “Gareth Morgan Investments Limited Partnership Decreases Stake in UnitedHealth Group Incorporated (UNH)” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/11/12/gareth-morgan-investments-limited-partnership-decreases-stake-in-unitedhealth-group-incorporated-unh.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.